Grand River Aseptic Manufacturing Raises Funds for Expansion - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Grand River Aseptic Manufacturing Raises Funds for Expansion



Grand River Aseptic Manufacturing (GRAM), a CMO for aseptic pharmaceutical filling, received $9.8 million in capital to expand its facilities, which will create life science jobs in West Michigan. Municipal Employees’ Retirement System (MERS) of Michigan, a nonprofit organization, led the $9.8 million investment round, supported by other Michigan and Indiana-based investors.

“We are delighted with the strong investor response, especially by MERS,” said Tom Ross, GRAM president. “Their considerable support, in combination with the backing from many private investors in our community, is a strong indicator that we’re headed in the right direction. This funding enables us to expand our capabilities, improve our facility, and advance our customer reach, all while creating more highly technical, high-paying jobs in West Michigan.”

Source: Grand River Aseptic Manufacturing

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here